Tina M. Albertson - Aug 19, 2024 Form 4 Insider Report for Caribou Biosciences, Inc. (CRBU)

Role
Chief Medical Officer
Signature
/s/ Barbara G. McClung, attorney-in-fact
Stock symbol
CRBU
Transactions as of
Aug 19, 2024
Transactions value $
$0
Form type
4
Date filed
8/20/2024, 04:07 PM
Previous filing
Aug 20, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CRBU Option to purchase Common Stock Award $0 +300K $0.00 300K Aug 19, 2024 Common Stock 300K $2.18 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the options will vest upon the one-year anniversary of the grant date, August 19, 2025, and 1/48th will vest monthly thereafter over the 36-month period following the one-year cliff, subject to the reporting person's continued service to the Issuer through the applicable vesting dates.